
We're answering your questions about the pandemic. Send yours to COVID@cbc.ca and we’ll answer as many as we can. We’ll publish a selection of answers every weekday online, and also put some questions to the experts during The National and on CBC News Network.
from CBC | Health News https://ift.tt/2VPNHdW
Aucun commentaire:
Enregistrer un commentaire